Skip to main content

Table 2 Description of clinical and psychosocial factors of participants with schizophrenia spectrum disorders in Comprehensive Specialized Hospitals, Amhara region, Ethiopia, 2020 (n = 404)

From: Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study

Variables

Frequency (404)

Percentage (%)

Clinical diagnosis

 Schizophrenia

346

85.6

 Schizophreniform

9

2.2

 Schizo-affective

26

6.4

 Delusional

16

4

 Brief psychotic

7

1.8

Age of onset

  < 20 years

44

10.9

  ≥ 20 years

360

89.1

Delayed treatment

  < 1 month

123

30.5

 1–6 months

87

21.5

  > 6 months

194

48.0

Duration on treatment

 Within 5 years

302

74.8

  > 5 years

102

25.2

Types of medication taking

 First generation APS

183

45.3

 Second generation APS

171

42.3

 Combination of first and second generation APS

2

0.5

 Others*

48

11.9

Previous suicidal ideation

 Yes

15

3.7

 No

389

96.3

Comorbid of another mental illnesses

 Yes

92

22.8

 No

312

77.2

Comorbid another medical illness

 Yes

47

11.6

 No

357

88.4

Medication adherence

 Adherent

301

74.5

 Non adherent

103

25.5

Medication side effect

 Mild side effect

237

58.7

 Moderate side effect

133

32.9

 Severe side effect

34

8.4

Social support

 Poor support

151

37.4

 Moderate support

142

35.1

 Severe support

111

27.5

Stressful event

 No stressful event

53

13.1

 1or 2 stressful events

134

33.2

  ≥ 3 stressful events

217

53.7

  1. * = Antipsychotic and antidepressants, antipsychotic and mood stabilizers; APS Antipsychotics